B
CELG

Brightworth’s Celgene Corp CELG Stock Holding History

Brightworth’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-2,300
Closed -$213K – 94
2019
Q2 		$213K Sell
2,300
-400
-15% -$38K 0.05% 85
2019
Q1 		$255K Buy
+2,700
New +$236K 0.05% 81
2018
Q4 		– Sell
-2,728
Closed -$244K – 102
2018
Q3 		$244K Sell
2,728
-972
-26% -$85.9K 0.05% 83
2018
Q2 		$294K Buy
+3,700
New +$307K 0.07% 74
2017
Q4 		– Sell
-1,420
Closed -$207K – 132
2017
Q3 		$207K Buy
+1,420
New +$193K 0.05% 120

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Brightworth's CELG Position: Q3 2019 in Review

Brightworth sold out of Celgene Corp (CELG) in Q3 2019, closing a stake of 2,300 shares — an estimated $213K sold.

Brightworth first reported a position in CELG in Q3 2017 and held it in 5 quarters. The position peaked at $294K in Q2 2018. 1,245 funds tracked by Wall St. Rank hold CELG as of Q3 2019.

  • Brightworth reported no remaining Celgene Corp position as of Q3 2019 after selling out during the quarter.
  • Brightworth sold 2,300 Celgene Corp shares in Q3 2019, an estimated $213K.
  • Brightworth first reported a position in Celgene Corp in Q3 2017 and held it in 5 quarters.
  • Brightworth's Celgene Corp position peaked at $294K in Q2 2018.
  • 1,245 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2019.

Based on Brightworth's 13F filing for Q3 2019, filed 1 Nov 2019.